ESOPJul 2, 2026, 07:01 AM
BioCryst Grants 125,700 Equity Awards to Nine New Employees
AI Summary
BioCryst Pharmaceuticals announced that its compensation committee granted equity awards to nine newly-hired employees. These awards include stock options to purchase an aggregate of 33,950 shares and restricted stock units (RSUs) covering an aggregate of 91,750 shares of BioCryst common stock. The grants, made on July 1, 2026, serve as material inducements for their employment and will vest in four equal annual installments.
Key Highlights
- Granted stock options and RSUs to nine newly-hired employees.
- Aggregate of 33,950 shares for stock options.
- Aggregate of 91,750 shares for restricted stock units (RSUs).
- Options have an exercise price of $9.65 per share.
- Options and RSUs vest in four equal annual installments.
- Vesting begins on the one-year anniversary of the grant date.
Price Impact
More from BCRX